Core Laboratories N.V. (CLB)
Stock Price:
$24.09 USD
-0.39 (-1.59%)
Updated November 27, 1:00 PM EST - Market closed
Key Info
| Market Cap |
1.07B |
| Revenue (ttm) |
530.30M |
| Net Income (ttm) |
-100.84M |
| Shares Out |
44.49M |
| EPS (ttm) |
-2.27 |
| PE Ratio |
n/a |
| Forward PE |
31.35 |
| Dividend |
$0.04 |
| Dividend Yield |
0.17% |
Stock Quote
| Trading Day |
November 27 |
| Last Price |
$24.09 |
| Previous Close |
$24.48 |
| Change ($) |
-0.39 |
| Change (%) |
-1.59% |
| Day's Open |
24.13 |
| Day's Range |
23.88 - 24.47 |
| Day's Volume |
199,274 |
| 52-Week Range |
6.68 - 48.40 |
More Stats
| Market Cap |
1.07B |
| Enterprise Value |
1.39B |
| Earnings Date (est) |
Feb 3, 2021 |
| Ex-Dividend Date |
Oct 23, 2020 |
| Shares Outstanding |
44.49M |
| Float |
43.96M |
| EPS (basic) |
-2.27 |
| EPS (diluted) |
-2.27 |
| FCF / Share |
1.76 |
| Dividend |
$0.04 |
| Dividend Yield |
0.17% |
| Earnings Yield |
n/a |
| FCF Yield |
7.29% |
| Payout Ratio |
n/a |
| Shares Short |
4.69M |
| Short Ratio |
9.67 |
| Short % of Float |
10.68% |
| Beta |
3.16 |
| PE Ratio |
n/a |
| Forward PE |
31.35 |
| P/FCF Ratio |
13.71 |
| PS Ratio |
2.02 |
| PB Ratio |
16.11 |
| Revenue |
530.30M |
| Operating Income |
-79.15M |
| Net Income |
-100.84M |
| Free Cash Flow |
78.18M |
| Net Cash |
-317.88M |
| Net Cash / Share |
-7.14 |
| Gross Margin |
32.55% |
| Operating Margin |
-14.93% |
| Profit Margin |
-19.00% |
| FCF Margin |
14.74% |
| ROA |
5.51% |
| ROE |
-75.66% |
| ROIC |
-10.70% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (16)
| Buy |
5 |
| Overweight |
1 |
| Hold |
9 |
| Underweight |
0 |
| Sell |
1 |
Analyst Consensus: Overweight
Price Target
$18.78*
(-22.04% downside)
Low
15.0
Current: $24.09
High
22.0
Target: 18.78
*Average 12-month price target from 14 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 668 | 701 | 648 | 590 | 798 | 1,085 | 1,074 | 981 | 908 | 795 |
| Revenue Growth | -4.66% | 8.19% | 9.76% | -25.99% | -26.51% | 1.09% | 9.42% | 8.09% | 14.22% | - |
| Gross Profit | 173 | 204 | 183 | 153 | 265 | 420 | 411 | 359 | 314 | 281 |
| Operating Income | 96.68 | 119 | 110 | 87.45 | 161 | 347 | 333 | 297 | 251 | 227 |
| Net Income | 102 | 79.53 | 83.13 | 63.90 | 115 | 257 | 243 | 216 | 185 | 145 |
| Shares Outstanding | 44.36 | 44.21 | 44.15 | 43.48 | 42.75 | 44.36 | 45.69 | 47.21 | 46.29 | 44.83 |
| Earnings Per Share | 2.28 | 1.79 | 1.88 | 1.46 | 2.68 | 5.77 | 5.28 | 4.54 | 3.82 | 3.00 |
| EPS Growth | 27.37% | -4.79% | 28.77% | -45.52% | -53.55% | 9.28% | 16.3% | 18.85% | 27.33% | - |
| Dividend Per Share | 2.20 | 2.20 | 2.20 | 2.20 | 2.20 | 2.00 | 1.28 | 1.12 | 1.00 | 0.89 |
| Dividend Growth | 0% | 0% | 0% | 0% | 10% | 56.25% | 14.29% | 12% | 12.36% | - |
| Operating Cash Flow | 89.53 | 112 | 124 | 132 | 219 | 303 | 298 | 237 | 204 | 206 |
| Capital Expenditures | -21.56 | -22.05 | -18.45 | -10.96 | -22.94 | -36.56 | -37.91 | -32.13 | -29.25 | -27.13 |
| Free Cash Flow | 67.97 | 89.78 | 106 | 121 | 196 | 267 | 260 | 205 | 175 | 179 |
| Cash & Equivalents | 11.09 | 13.12 | 14.40 | 14.76 | 22.49 | 23.35 | 25.09 | 19.23 | 29.33 | 134 |
| Total Debt | 382 | 290 | 227 | 216 | 431 | 354 | 267 | 234 | 223 | 148 |
| Net Cash / Debt | -371 | -277 | -213 | -202 | -408 | -330 | -242 | -215 | -194 | -13.66 |
| Assets | 775 | 649 | 585 | 573 | 625 | 673 | 661 | 637 | 611 | 650 |
| Liabilities | 593 | 488 | 436 | 418 | 649 | 579 | 492 | 449 | 429 | 358 |
| Book Value | 178 | 157 | 145 | 151 | -29.06 | 87.57 | 163 | 182 | 178 | 289 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Core Laboratories N.V. |
| Country |
Netherlands |
| Employees |
3,800 |
| CEO |
Lawrence V. Bruno |
Stock Information
| Ticker Symbol |
CLB |
| Stock Exchange |
New York Stock Exchange |
| Sector |
Energy |
| Industry |
Oil & Gas Equipment & Services |
| Unique Identifier |
NYSE: CLB |
| IPO Date |
September 20, 1995 |
Description
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment comprises services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.